Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Squinto Stephen P
Relationship:   Director, 10% Owner
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   238,160    

Indirect Shares

   6,290,493      
Direct Value   $19,437,710    

Indirect Value

   $19,013,945      
Total Shares   6,528,653      
Total Value   $38,451,655      


Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0 Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN EVP, Chief Global Ops.... 2014-10-27 106,508 2013-10-28 104,186    Premium*  
            Springworks Therapeutics, Inc. SWTX Director, 10% Owner 2022-05-19 131,652 2022-05-19 6,186,307    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-11-04 4 OE $22.90 $446,963 D/D 14,125 118,311 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-11-04 4 AS $123.82 $1,749,664 D/D (14,125) 104,186 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2004-12-20 4 AS $25.00 $361,995 D/D (14,440) 11,876 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-02-16 4 S $46.60 $745,600 D/D (16,000) 35,454 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-02-16 4 OE $13.79 $220,640 D/D 16,000 51,454 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-07-12 4 AS $119.90 $2,158,200 D/D (18,000) 108,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-07-12 4 OE $17.98 $378,370 D/D 18,000 126,462 0 -
ALXN Alexion Pharmaceuticals I... Executive VP& Head of Research   •       –      –    2004-08-16 4 OE $2.38 $43,047 D/D 18,125 23,601 -
ALXN Alexion Pharmaceuticals I... Exec VP & Head of Research   •       –      –    2004-09-15 4 OE $2.38 $43,047 D/D 18,125 31,726 -
ALXN Alexion Pharmaceuticals I... EVP, Head of Research   •       –      –    2004-10-15 4 AS $16.65 $309,696 D/D (18,125) 31,726 -
ALXN Alexion Pharmaceuticals I... EVP, Head of Research   •       –      –    2004-10-15 4 OE $2.38 $43,047 D/D 18,125 49,851 -
SWTX Springworks Therapeutics,... Director   –       •       •   2021-04-28 4 AS $76.20 $1,465,437 D/D (19,231) 125,728 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-03-08 4 OE $17.98 $390,350 D/D 20,000 128,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-03-08 4 S $91.21 $1,827,162 D/D (20,000) 108,462 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-06-01 4 OE $9.00 $229,375 D/D 25,000 50,014 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-06-01 4 AS $48.50 $1,212,500 D/D (25,000) 25,014 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-07-25 4 OE $9.00 $242,425 D/D 25,000 45,512 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-07-25 4 AS $56.50 $1,414,306 D/D (25,000) 20,512 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-26 4 S $57.34 $1,605,520 D/D (28,000) 78,270 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-26 4 OE $10.29 $288,120 D/D 28,000 106,270 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-02-04 4 OE $22.90 $1,656,469 D/D 28,739 124,455 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-11-05 4 OE $21.00 $702,765 D/D 33,465 48,770 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2011-01-18 4 OE $10.36 $496,000 D/D 34,000 68,247 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2011-01-18 4 AS $82.66 $2,919,280 D/D (34,346) 34,247 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-11-05 4 AS $75.03 $2,625,900 D/D (34,998) 13,772 0 -
  148  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us